• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by ReWalk Robotics Ltd. (Amendment)

    2/11/22 8:06:37 AM ET
    $RWLK
    Industrial Specialties
    Health Care
    Get the next $RWLK alert in real time by email
    SC 13G/A 1 ea155282-13ga2intra_rewalk.htm AMENDMENT NO. 2 TO SCHEDULE 13G

     

     

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

     

    SCHEDULE 13G

     

    Under the Securities Exchange Act of 1934

     

    (Amendment No. 2)*

     

    ReWalk Robotics Ltd.

     

    (Name of Issuer)

     

    Ordinary Shares, NIS 0.25 par value per share

     

    (Title of Class of Securities)

     

    M8216Q200

     

    (CUSIP Number)

     

    December 31, 2021

     

    (Date of Event Which Requires Filing of this Statement)

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

    a.☐ Rule 13d-1(b)
    b.☒ Rule 13d-1(c)
    c.☐ Rule 13d-1(d)

     

    *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

     

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     

    Page 1 of 6

     

     

    CUSIP No. M8216Q200  

     

    1. Names of Reporting Persons.
       
      Mitchell P. Kopin
    2. Check the Appropriate Box if a Member of a Group (See Instructions)
       
      (a) ☐
      (b) ☐
    3. SEC Use Only
         
    4. Citizenship or Place of Organization United States of America
         

    Number of

    Shares Beneficially

    Owned by Each

    Reporting

    Person With:

    5. Sole Voting Power 0
         
    6. Shared Voting Power 2,385,280
         
    7. Sole Dispositive Power 0
         
    8. Shared Dispositive Power 2,385,280
           
    9. Aggregate Amount Beneficially Owned by Each Reporting Person 2,385,280 (see Item 4)
         
    10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ☐
         
    11. Percent of Class Represented by Amount in Row (9) 3.7% (see Item 4)
         
    12. Type of Reporting Person (See Instructions)  
         
      IN; HC  

     

    Page 2 of 6

     

     

    CUSIP No. M8216Q200  

     

    1. Names of Reporting Persons.
       
      Daniel B. Asher
    2. Check the Appropriate Box if a Member of a Group (See Instructions)
       
      (a) ☐
      (b) ☐
    3. SEC Use Only
         
    4. Citizenship or Place of Organization United States of America
         

    Number of

    Shares Beneficially

    Owned by Each

    Reporting

    Person With:

    5. Sole Voting Power 0
         
    6. Shared Voting Power 2,385,280
         
    7. Sole Dispositive Power 0
         
    8. Shared Dispositive Power 2,385,280
           
    9. Aggregate Amount Beneficially Owned by Each Reporting Person 2,385,280 (see Item 4)
         
    10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ☐
         
    11. Percent of Class Represented by Amount in Row (9) 3.7% (see Item 4)
         
    12. Type of Reporting Person (See Instructions)  
         
      IN; HC  

     

    Page 3 of 6

     

     

    CUSIP No. M8216Q200

     

    1. Names of Reporting Persons.
       
      Intracoastal Capital LLC
    2. Check the Appropriate Box if a Member of a Group (See Instructions)
       
      (a) ☐
      (b) ☐
    3. SEC Use Only
         
    4. Citizenship or Place of Organization Delaware
         

    Number of

    Shares Beneficially

    Owned by Each

    Reporting

    Person With:

    5. Sole Voting Power 0
         
    6. Shared Voting Power 2,385,280
         
    7. Sole Dispositive Power 0
         
    8. Shared Dispositive Power 2,385,280
           
    9. Aggregate Amount Beneficially Owned by Each Reporting Person 2,385,280 (see Item 4)
         
    10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ☐
         
    11. Percent of Class Represented by Amount in Row (9) 3.7% (see Item 4)
         
    12. Type of Reporting Person (See Instructions)  
         
      OO  

     

    Page 4 of 6

     

     

    This Amendment No. 2 is being filed jointly by the Reporting Persons and amends the Schedule 13G initially filed by the Reporting Persons with the Securities and Exchange Commission (the “SEC”) on February 18, 2020, as amended by Amendment No. 1 thereto filed by the Reporting Persons with the SEC on January 29, 2021 (the “Schedule 13G”).

     

    Except as set forth below, all Items of the Schedule 13G remain unchanged. All capitalized terms not otherwise defined herein shall have the meanings ascribed to such terms in the Schedule 13G.

     

    Item 4. Ownership.

     

    (a) and (b):

     

    As of the close of business on December 31, 2021, each of the Reporting Persons may have been deemed to have beneficial ownership of 2,385,280 shares of Common Stock, which consisted of (i) 136,152 shares of Common Stock issuable upon exercise of a warrant held by Intracoastal (“Intracoastal Warrant 1”), (ii) 166,667 shares of Common Stock issuable upon exercise of a second warrant held by Intracoastal (“Intracoastal Warrant 2”), (iii) 411,523 shares of Common Stock issuable upon exercise of a third warrant held by Intracoastal (“Intracoastal Warrant 3”), (iv) 32,880 shares of Common Stock issuable upon exercise of a fourth warrant held by Intracoastal (“Intracoastal Warrant 4”), (v) 1,228,502 shares of Common Stock issuable upon exercise of a fifth warrant held by Intracoastal (“Intracoastal Warrant 5”) and (vi) 409,556 shares of Common Stock issuable upon exercise of a sixth warrant held by Intracoastal (“Intracoastal Warrant 6”), and all such shares of Common Stock represented beneficial ownership of approximately 3.7% of the Common Stock, based on (1) 62,455,859 shares of Common Stock outstanding as of November 10, 2021 as reported by the Issuer, plus (2) 136,152 shares of Common Stock issuable upon exercise of Intracoastal Warrant 1, (3) 166,667 shares of Common Stock issuable upon exercise of Intracoastal Warrant 2, (4) 411,523 shares of Common Stock issuable upon exercise of Intracoastal Warrant 3, (5) 32,880 shares of Common Stock issuable upon exercise of Intracoastal Warrant 4, (6) 1,228,502 shares of Common Stock issuable upon exercise of Intracoastal Warrant 5 and (7) 409,556 shares of Common Stock issuable upon exercise of Intracoastal Warrant 6.

     

    (c) Number of shares as to which each Reporting Person has:

     

    (i) Sole power to vote or to direct the vote: 0.

     

    (ii) Shared power to vote or to direct the vote: 2,385,280.

     

    (iii) Sole power to dispose or to direct the disposition of 0.

     

    (iv) Shared power to dispose or to direct the disposition of 2,385,280.

     

    Item 5. Ownership of Five Percent or Less of a Class

     

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following þ.

     

    Item 10. Certification

     

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §240.14a-11. 

     

    Page 5 of 6

     

     

    SIGNATURE

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    Date: February 11, 2022

     

      /s/ Mitchell P. Kopin
      Mitchell P. Kopin
       
      /s/ Daniel B. Asher
      Daniel B. Asher

     

      Intracoastal Capital LLC
         
      By: /s/ Mitchell P. Kopin
        Mitchell P. Kopin, Manager

     

    Page 6 of 6

     

    Get the next $RWLK alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $RWLK

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $RWLK
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • VA STAND Act introduced in the United States Senate

      MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, March 22, 2024 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (DBA Lifeward™), (NASDAQ:LFWD) ("Lifeward" or the "Company"), a global market leader delivering life-changing solutions to revolutionize what is possible in rehabilitation, recovery, and the pursuit of life's passions in the face of physical limitation or disability, today applauded the introduction of a Senate companion bill to H.R. 6373, the VA Spinal Trauma Access to New Devices (STAND) Act. The Senate companion bill was introduced by Chairman of the Senate Veterans' Affairs Committee, Senator Jon Tester (D-MT), and the Ranking Member of that committee, Senator Jerry Moran (R-KS).

      3/22/24 8:30:00 AM ET
      $LFWD
      $RWLK
      Industrial Specialties
      Health Care
    • Lifeward Announces Reverse Share Split

      Reverse split initiated to regain compliance with Nasdaq listing requirements Financial guidance for 2024 and profitability target for 2026 on existing capital remain unchanged MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, March 13, 2024 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (DBA Lifeward™), (NASDAQ:LFWD) ("Lifeward" or the "Company"), a global market leader delivering life-changing solutions to revolutionize what is possible in rehabilitation, recovery, and the pursuit of life's passions in the face of physical limitation or disability, today announced that effective with the open of the market on Friday, March 15, 2024, the Company will complete a 1-for-7 reverse

      3/13/24 11:45:17 AM ET
      $LFWD
      $RWLK
      Industrial Specialties
      Health Care
    • ReStore Exo-Suit Publications Demonstrate Improved Walking Outcomes Versus Conventional Stroke Therapy

      Randomized clinical trial demonstrates significant improvements in walking ability for patients receiving therapy with the ReStore Exo-Suit as compared to a matched control group receiving conventional stroke therapy. Additional study demonstrates that the improvements in walking speed and distance following high-intensity gait training with the ReStore Exo-Suit were maintained by individuals post-stroke 4 weeks after the intervention had concluded. Combined results highlight the clinical value of the ReStore Exo-Suit and its related breakthrough propulsion-augmenting technologies within the Lifeward product development pipeline. MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, M

      3/8/24 8:30:00 AM ET
      $LFWD
      $RWLK
      Industrial Specialties
      Health Care

    $RWLK
    Leadership Updates

    Live Leadership Updates

    See more
    • ReWalk Robotics Appoints Michael Lawless as Chief Financial Officer

      MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, Sept. 08, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (NASDAQ:RWLK) (the "Company" or "ReWalk"), a leading manufacturer of robotic medical technology for people with lower extremity disabilities, today announced the appointment of Michael Lawless, CPA, as Chief Financial Officer, effective September 19, 2022. Mr. Lawless brings more than 20 years of experience leading finance and investor relations activities at life science and technology companies to drive greater financial discipline, better strategic decision making, and improved access to capital. "Mike brings an extensive background in strategic finance and investor relations

      9/8/22 8:30:34 AM ET
      $RWLK
      Industrial Specialties
      Health Care
    • ReWalk Robotics Confirms Receipt of Director Candidate Nominations from Creative Value Capital

      Shareholders Are Not Required to Take Action at This Time MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, May 19, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (NASDAQ:RWLK) ("ReWalk" or the "Company"), a leading manufacturer of robotic medical technology for people with lower extremity disabilities, today announced that it has received notice from Creative Value Capital Limited Partnership ("CVC"), which claims to hold approximately 3% of ReWalk's outstanding shares, that it intends to nominate two candidates for election to the Company's Board of Directors (the "Board") and submit two additional proposals for consideration at the 2022 Annual Meeting of Shareholders (the "Annual

      5/19/22 7:55:01 AM ET
      $RWLK
      Industrial Specialties
      Health Care
    • ReWalk Robotics Announces the Appointment of Joseph E. Turk, Jr. to their Board of Directors

      MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, April 20, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics. Ltd. (NASDAQ:RWLK) ("ReWalk" or "The Company"), a leading manufacturer of robotic medical technology for people with lower extremity disabilities, announced today that the Board has approved the appointment of Joseph Turk, Jr. to the Board of Directors, effective today. After initiating his career at McKinsey and Company, Mr. Turk has assembled an extensive history in the medical device industry beginning with his role as Director of New Business Development at Boston Scientific. Subsequently, he held multiple roles at NxStage Medical, including President, where he led all commercialization

      4/20/22 4:05:07 PM ET
      $RWLK
      Industrial Specialties
      Health Care

    $RWLK
    Financials

    Live finance-specific insights

    See more
    • Lifeward Reports Fourth Quarter and Full Year 2023 Financial Results

      Highest quarterly and annual revenue in the history of LifewardCommercial and operational integration complete; synergiesexpected to yield $3 million in annual net savings MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Feb. 27, 2024 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (DBA Lifeward™), (NASDAQ:LFWD) ("Lifeward" or the "Company"), a global market leader delivering life-changing solutions to revolutionize what is possible in rehabilitation, recovery, and the pursuit of life's passions in the face of physical limitation or disability, today announced its financial results for the three months and full year ended December 31, 2023. Highlights of the Fourth Quarter of 2023 and Early 2024

      2/27/24 8:00:07 AM ET
      $LFWD
      $RWLK
      Industrial Specialties
      Health Care
    • Lifeward to Report Fourth Quarter and Fiscal Year-End 2023 Financial Results on February 27, 2024

      MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Feb. 20, 2024 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (DBA Lifeward™), (NASDAQ:LFWD) ("Lifeward" or the "Company"), a global market leader delivering life-changing solutions to revolutionize what is possible in rehabilitation, recovery, and the pursuit of life's passions in the face of physical limitation or disability, today announced that the Company will release its fourth quarter and fiscal year-end 2023 financial results before the markets open on Tuesday, February 27, 2024. Larry Jasinski, Chief Executive Officer, and Michael Lawless, Chief Financial Officer, will host a conference call and live webcast at 8:30 a.m. EST to discuss the f

      2/20/24 8:30:00 AM ET
      $LFWD
      $RWLK
      Industrial Specialties
      Health Care
    • ReWalk Robotics Reports Third Quarter 2023 Financial Results

      Record Quarterly Revenue of $4.4 Million Successful Completion of AlterG Acquisition and Significant Progress of Integration Major Advancement in Efforts to Attain Medicare Payment Coverage of Exoskeletons MARLBOROUGH, Mass., BERLIN and YOKNEAM ILLIT, Israel, Nov. 14, 2023 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (NASDAQ:RWLK) ("ReWalk" or the "Company"), a leading provider of innovative technologies that enable mobility and wellness in rehabilitation and daily life for individuals with neurological conditions, today announced its financial results for the three and nine months ended September 30, 2023. Highlights of the Third Quarter of 2023 include: Closing of ReWalk's acquisition o

      11/14/23 8:06:13 AM ET
      $RWLK
      Industrial Specialties
      Health Care

    $RWLK
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Lind Global Fund Ii Lp bought $40,089 worth of Ordinary Shares (54,917 units at $0.73) (SEC Form 4)

      4 - ReWalk Robotics Ltd. (0001607962) (Issuer)

      11/21/23 4:37:18 PM ET
      $RWLK
      Industrial Specialties
      Health Care
    • Lind Global Fund Ii Lp bought $49,516 worth of Ordinary Shares (72,818 units at $0.68) (SEC Form 4)

      4 - ReWalk Robotics Ltd. (0001607962) (Issuer)

      11/16/23 4:37:44 PM ET
      $RWLK
      Industrial Specialties
      Health Care
    • Lind Global Fund Ii Lp sold $3,521,840 worth of Ordinary Shares (5,031,200 units at $0.70) and bought $3,521,840 worth of Ordinary Shares (5,031,200 units at $0.70) (SEC Form 4)

      4 - ReWalk Robotics Ltd. (0001607962) (Issuer)

      9/28/23 4:30:24 PM ET
      $RWLK
      Industrial Specialties
      Health Care

    $RWLK
    SEC Filings

    See more
    • ReWalk Robotics Ltd. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

      8-K - ReWalk Robotics Ltd. (0001607962) (Filer)

      1/30/24 4:15:24 PM ET
      $RWLK
      Industrial Specialties
      Health Care
    • ReWalk Robotics Ltd. filed SEC Form 8-K: Other Events

      8-K - ReWalk Robotics Ltd. (0001607962) (Filer)

      12/19/23 4:04:05 PM ET
      $RWLK
      Industrial Specialties
      Health Care
    • ReWalk Robotics Ltd. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - ReWalk Robotics Ltd. (0001607962) (Filer)

      10/13/23 4:31:13 PM ET
      $RWLK
      Industrial Specialties
      Health Care

    $RWLK
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more

    $RWLK
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • HC Wainwright reiterated coverage on ReWalk Robotics with a new price target

      HC Wainwright reiterated coverage of ReWalk Robotics with a rating of Buy and set a new price target of $3.50 from $2.50 previously

      3/8/21 8:24:25 AM ET
      $RWLK
      Industrial Specialties
      Health Care
    • HC Wainwright & Co. reiterated coverage on ReWalk Robotics with a new price target

      HC Wainwright & Co. reiterated coverage of ReWalk Robotics with a rating of Buy and set a new price target of $3.50 from $2.50 previously

      3/1/21 7:05:13 AM ET
      $RWLK
      Industrial Specialties
      Health Care
    • Lind Global Fund Ii Lp bought $40,089 worth of Ordinary Shares (54,917 units at $0.73) (SEC Form 4)

      4 - ReWalk Robotics Ltd. (0001607962) (Issuer)

      11/21/23 4:37:18 PM ET
      $RWLK
      Industrial Specialties
      Health Care
    • Lind Global Fund Ii Lp bought $49,516 worth of Ordinary Shares (72,818 units at $0.68) (SEC Form 4)

      4 - ReWalk Robotics Ltd. (0001607962) (Issuer)

      11/16/23 4:37:44 PM ET
      $RWLK
      Industrial Specialties
      Health Care
    • Lind Global Fund Ii Lp sold $3,521,840 worth of Ordinary Shares (5,031,200 units at $0.70) and bought $3,521,840 worth of Ordinary Shares (5,031,200 units at $0.70) (SEC Form 4)

      4 - ReWalk Robotics Ltd. (0001607962) (Issuer)

      9/28/23 4:30:24 PM ET
      $RWLK
      Industrial Specialties
      Health Care

    $RWLK
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13D/A filed by ReWalk Robotics Ltd. (Amendment)

      SC 13D/A - ReWalk Robotics Ltd. (0001607962) (Subject)

      9/28/23 4:30:11 PM ET
      $RWLK
      Industrial Specialties
      Health Care
    • SEC Form SC 13D/A filed by ReWalk Robotics Ltd. (Amendment)

      SC 13D/A - ReWalk Robotics Ltd. (0001607962) (Subject)

      3/9/23 4:20:24 PM ET
      $RWLK
      Industrial Specialties
      Health Care
    • SEC Form SC 13D filed by ReWalk Robotics Ltd.

      SC 13D - ReWalk Robotics Ltd. (0001607962) (Subject)

      2/22/23 5:21:58 PM ET
      $RWLK
      Industrial Specialties
      Health Care